血糖与血脂危险因素在BMI对冠心病影响中的中介作用:两步法两样本孟德尔随机化研究
采用两步法两样本孟德尔随机化,评估BMI对冠心病的影响及血糖和血脂特征的中介作用。BMI每升高1个标准差(约4.5 kg/m2)与冠心病风险升高相关(OR 1.45,95%CI 1.27–1.66);对甘油三酯或HbA1c进行遗传学校正后,BMI-冠心病效应分别降至1.16(95%CI 0.99–1.36)和1.36(95%CI 1.19–1.57),同时校正两者后降至1.09(95%CI 0.94–1.27)。结论认为甘油三酯水平升高和血糖控制不佳似乎介导了BMI对冠心病的大部分影响。
要点
- BMI每升高1个标准差(约4.5 kg/m2)与冠心病风险升高相关(OR 1.45,95%CI 1.27–1.66)。
- BMI与甘油三酯、HbA1c、空腹血糖、空腹胰岛素及2型糖尿病风险升高相关,与HDL-胆固醇降低相关。
- 遗传学校正甘油三酯或HbA1c后BMI-冠心病效应减弱,同时校正两者后降至1.09(95%CI 0.94–1.27)。
核心结论
- 甘油三酯水平升高和血糖控制不佳似乎介导了BMI对冠心病的大部分影响。
研究设计与样本
- 两步法两样本孟德尔随机化研究,评估BMI对冠心病、2型糖尿病、空腹血糖、胰岛素、HbA1c及血脂特征的因果效应,并评估这些特征的中介程度。
- 冠心病分析纳入60,801例病例和123,504例对照;2型糖尿病分析纳入34,840例病例和114,981例对照。
- 空腹血糖分析n=46,186,胰岛素分析n=38,238,HbA1c分析n=46,368,LDL-胆固醇、HDL-胆固醇和甘油三酯分析n=188,577。
主要发现
- BMI每升高1个标准差(约4.5 kg/m2)与冠心病风险升高相关(OR 1.45,95%CI 1.27–1.66),与2型糖尿病风险升高相关(OR 1.96,95%CI 1.35–2.83)。
- BMI每升高1个标准差与空腹血糖升高0.07 mmol/l(95%CI 0.03–0.11)、HbA1c升高0.05%(95%CI 0.01–0.08)、空腹胰岛素升高0.18 log pmol/l(95%CI 0.14–0.22)、甘油三酯升高0.20 SD(95%CI 0.14–0.26)及HDL-胆固醇降低0.23 SD(95%CI -0.32–-0.15)相关。
- 无证据表明BMI与LDL-胆固醇存在因果关联。
- 考虑不同水平多效性模型的敏感性分析后,较高甘油三酯、HbA1c和糖尿病风险与冠心病风险的因果关联仍存在。
- 对甘油三酯进行遗传学校正后,BMI-冠心病效应从1.45降至1.16(95%CI 0.99–1.36);对HbA1c校正后降至1.36(95%CI 1.19–1.57);同时校正两者后降至1.09(95%CI 0.94–1.27)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The extent to which effects of BMI on CHD are mediated by glycaemic and lipid risk factors is unclear. In this study we examined the effects of these traits using genetic evidence. METHODS: We used two-sample Mendelian randomisation to determine: (1) the causal effect of BMI on CHD (60,801 case vs 123,504 control participants), type 2 diabetes (34,840 case vs 114,981 control participants), fasting glucose (n = 46,186), insulin (n = 38,238), HbA1c (n = 46,368) and LDL-cholesterol, HDL-cholesterol and triacylglycerols (n = 188,577); (2) the causal effects of glycaemic and lipids traits on CHD; and (3) the extent to which these traits mediate any effect of BMI on CHD. RESULTS: One SD higher BMI (~ 4.5 kg/m2) was associated with higher risk of CHD (OR 1.45 [95% CI 1.27, 1.66]) and type 2 diabetes (1.96 [95% CI 1.35, 2.83]), higher levels of fasting glucose (0.07 mmol/l [95% CI 0.03, 0.11]), HbA1c (0.05% [95% CI 0.01, 0.08]), fasting insulin (0.18 log pmol/l [95% CI 0.14, 0.22]) and triacylglycerols (0.20 SD [95% CI 0.14, 0.26]) and lower levels of HDL-cholesterol (-0.23 SD [95% CI -0.32, -0.15]). There was no evidence for a causal relation between BMI and LDL-cholesterol. The causal associations of higher triacylglycerols, HbA1c and diabetes risk with CHD risk remained after performing sensitivity analyses that considered different models of horizontal pleiotropy. The BMI-CHD effect reduced from 1.45 to 1.16 (95% CI 0.99, 1.36) and to 1.36 (95% CI 1.19, 1.57) with genetic adjustment for triacylglycerols or HbA1c, respectively, and to 1.09 (95% CI 0.94, 1.27) with adjustment for both. CONCLUSIONS/INTERPRETATION: Increased triacylglycerol levels and poor glycaemic control appear to mediate much of the effect of BMI on CHD.
引用
- Xu L, Borges MC, Hemani G, et al. The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study. Diabetologia. 2017. PMID: 28889241. doi:10.1007/s00125-017-4396-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。